TY  - JOUR
AU  - Todoric-Živanović, B
AU  - Marisavljevic, D
AU  - Surace, C
AU  - Cemerikic, V
AU  - Markovic, O
AU  - Krtolica-Žikić, Koviljka
AU  - Tatomirovic, Z
AU  - Cikota, B
AU  - Magic, Z
AU  - Rocchi, M
PY  - 2006
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/3011
AB  - Chronic myeloid leukemia (CML) is a clonal malignant disorder of a pluripotent hematopoetic stem cell characterized by the presence of the Philadelphia (Ph) chromosome in more than 90% of patients. Cryptic or masked BCR/ABL gene rearrangements may be found in cases with a normal karyotype and in cases with the complex karyotype, in which typical t(9;22) is not visible at the microscopic level. Those rearrangements can now be detected by fluorescence in situ hybridization. Here, we report on a novel and complex Ph chromosome-negative CML case with a t(6;9) (p21;q34.1) in which the BCR/ABL fusion gene is located at 6p21. (c) 2006 Elsevier Inc. All rights reserved.
T2  - Cancer Genetics and Cytogenetics
T1  - A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1)
VL  - 166
IS  - 2
SP  - 180
EP  - 185
DO  - 10.1016/j.cancergencyto.2005.11.008
ER  - 

@article{
author = "Todoric-Živanović, B and Marisavljevic, D and Surace, C and Cemerikic, V and Markovic, O and Krtolica-Žikić, Koviljka and Tatomirovic, Z and Cikota, B and Magic, Z and Rocchi, M",
year = "2006",
abstract = "Chronic myeloid leukemia (CML) is a clonal malignant disorder of a pluripotent hematopoetic stem cell characterized by the presence of the Philadelphia (Ph) chromosome in more than 90% of patients. Cryptic or masked BCR/ABL gene rearrangements may be found in cases with a normal karyotype and in cases with the complex karyotype, in which typical t(9;22) is not visible at the microscopic level. Those rearrangements can now be detected by fluorescence in situ hybridization. Here, we report on a novel and complex Ph chromosome-negative CML case with a t(6;9) (p21;q34.1) in which the BCR/ABL fusion gene is located at 6p21. (c) 2006 Elsevier Inc. All rights reserved.",
journal = "Cancer Genetics and Cytogenetics",
title = "A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1)",
volume = "166",
number = "2",
pages = "180-185",
doi = "10.1016/j.cancergencyto.2005.11.008"
}

Todoric-Živanović, B., Marisavljevic, D., Surace, C., Cemerikic, V., Markovic, O., Krtolica-Žikić, K., Tatomirovic, Z., Cikota, B., Magic, Z.,& Rocchi, M.. (2006). A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). in Cancer Genetics and Cytogenetics, 166(2), 180-185.
https://doi.org/10.1016/j.cancergencyto.2005.11.008

Todoric-Živanović B, Marisavljevic D, Surace C, Cemerikic V, Markovic O, Krtolica-Žikić K, Tatomirovic Z, Cikota B, Magic Z, Rocchi M. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1). in Cancer Genetics and Cytogenetics. 2006;166(2):180-185.
doi:10.1016/j.cancergencyto.2005.11.008 .

Todoric-Živanović, B, Marisavljevic, D, Surace, C, Cemerikic, V, Markovic, O, Krtolica-Žikić, Koviljka, Tatomirovic, Z, Cikota, B, Magic, Z, Rocchi, M, "A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1)" in Cancer Genetics and Cytogenetics, 166, no. 2 (2006):180-185,
https://doi.org/10.1016/j.cancergencyto.2005.11.008 . .

TY  - JOUR
AU  - Trutic, N
AU  - Magic, Z
AU  - Urosevic, N
AU  - Krtolica-Žikić, Koviljka
PY  - 2002
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2577
AB  - We studied the effect of total body X-irradiation and partial hepatectomy on the acute phase protein gene expression in rat liver. Male rats of AO strain were irradiated with high X-ray doses, without any visible tissue damage. In contrast, partial hepatectomy consisted of surgical removal of 40% liver tissue. The changes in liver mRNA concentrations for positive acute-phase reactants including cysteine protease inhibitor, alpha(1)-acid glycoprotein, fibrinogen and haptoglobin, and albumin as a negative reactant were monitored by Northern blot and slot-blot hybridizations using corresponding [P-32]dCTP labeled cDNA probes. While in the first 24 h after the partial hepatectomy, liver mRNA levels for the positive acute-phase reactants increased, briefly followed by an immediate decrease, the duration and timing of the acute-phase responses to the whole body X-irradiation were slightly different and lasted for as long as 72 h. Although both treatments induced the mRNA expression of acute-phase reactants in rat liver, the observed variations in the duration and intensity of the changes in mRNA levels for the acute-phase proteins in these two types of tissue damage suggest the involvement of specific mechanisms in a fine tuning of the non-specific acute-phase responses to meet the unique requirements of the particular injury. (C) 2002 Elsevier Science Inc. All rights reserved.
T2  - Comparative Biochemistry and Physiology. C: Toxicology and Pharmacology
T1  - Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy
VL  - 133
IS  - 3
SP  - 461
EP  - 470
DO  - 10.1016/S1532-0456(02)00174-6
ER  - 

@article{
author = "Trutic, N and Magic, Z and Urosevic, N and Krtolica-Žikić, Koviljka",
year = "2002",
abstract = "We studied the effect of total body X-irradiation and partial hepatectomy on the acute phase protein gene expression in rat liver. Male rats of AO strain were irradiated with high X-ray doses, without any visible tissue damage. In contrast, partial hepatectomy consisted of surgical removal of 40% liver tissue. The changes in liver mRNA concentrations for positive acute-phase reactants including cysteine protease inhibitor, alpha(1)-acid glycoprotein, fibrinogen and haptoglobin, and albumin as a negative reactant were monitored by Northern blot and slot-blot hybridizations using corresponding [P-32]dCTP labeled cDNA probes. While in the first 24 h after the partial hepatectomy, liver mRNA levels for the positive acute-phase reactants increased, briefly followed by an immediate decrease, the duration and timing of the acute-phase responses to the whole body X-irradiation were slightly different and lasted for as long as 72 h. Although both treatments induced the mRNA expression of acute-phase reactants in rat liver, the observed variations in the duration and intensity of the changes in mRNA levels for the acute-phase proteins in these two types of tissue damage suggest the involvement of specific mechanisms in a fine tuning of the non-specific acute-phase responses to meet the unique requirements of the particular injury. (C) 2002 Elsevier Science Inc. All rights reserved.",
journal = "Comparative Biochemistry and Physiology. C: Toxicology and Pharmacology",
title = "Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy",
volume = "133",
number = "3",
pages = "461-470",
doi = "10.1016/S1532-0456(02)00174-6"
}

Trutic, N., Magic, Z., Urosevic, N.,& Krtolica-Žikić, K.. (2002). Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy. in Comparative Biochemistry and Physiology. C: Toxicology and Pharmacology, 133(3), 461-470.
https://doi.org/10.1016/S1532-0456(02)00174-6

Trutic N, Magic Z, Urosevic N, Krtolica-Žikić K. Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy. in Comparative Biochemistry and Physiology. C: Toxicology and Pharmacology. 2002;133(3):461-470.
doi:10.1016/S1532-0456(02)00174-6 .

Trutic, N, Magic, Z, Urosevic, N, Krtolica-Žikić, Koviljka, "Acute-phase protein gene expression in rat liver following whole body X-irradiation or partial hepatectomy" in Comparative Biochemistry and Physiology. C: Toxicology and Pharmacology, 133, no. 3 (2002):461-470,
https://doi.org/10.1016/S1532-0456(02)00174-6 . .

TY  - CONF
AU  - Todoric, B
AU  - Malesevic, M
AU  - Stamatovic, D
AU  - Magic, Z
AU  - Balint, B
AU  - Krtolica-Žikić, Koviljka
PY  - 1999
UR  - https://vinar.vin.bg.ac.rs/handle/123456789/2236
C3  - Bone Marrow Transplantation
T1  - Minimal residual, disease in CML patients submitted to stem cell transplantation
VL  - 23
SP  - S151
EP  - S151
UR  - https://hdl.handle.net/21.15107/rcub_vinar_2236
ER  - 

@conference{
author = "Todoric, B and Malesevic, M and Stamatovic, D and Magic, Z and Balint, B and Krtolica-Žikić, Koviljka",
year = "1999",
journal = "Bone Marrow Transplantation",
title = "Minimal residual, disease in CML patients submitted to stem cell transplantation",
volume = "23",
pages = "S151-S151",
url = "https://hdl.handle.net/21.15107/rcub_vinar_2236"
}

Todoric, B., Malesevic, M., Stamatovic, D., Magic, Z., Balint, B.,& Krtolica-Žikić, K.. (1999). Minimal residual, disease in CML patients submitted to stem cell transplantation. in Bone Marrow Transplantation, 23, S151-S151.
https://hdl.handle.net/21.15107/rcub_vinar_2236

Todoric B, Malesevic M, Stamatovic D, Magic Z, Balint B, Krtolica-Žikić K. Minimal residual, disease in CML patients submitted to stem cell transplantation. in Bone Marrow Transplantation. 1999;23:S151-S151.
https://hdl.handle.net/21.15107/rcub_vinar_2236 .

Todoric, B, Malesevic, M, Stamatovic, D, Magic, Z, Balint, B, Krtolica-Žikić, Koviljka, "Minimal residual, disease in CML patients submitted to stem cell transplantation" in Bone Marrow Transplantation, 23 (1999):S151-S151,
https://hdl.handle.net/21.15107/rcub_vinar_2236 .